Consensus Afya Limited Sao Paulo

Stocks

A2FY34

BRA2FYBDR000

School, College & University

Delayed Sao Paulo Other stock markets 20:54:58 26/06/2026 BST			5-day change	1st Jan Change
39.57 ^BRL	+2.94%		+5.35%	-3.84%

05-08	Afya Q1 Earnings, Revenue Rise; Reaffirms 2026 Revenue Guidance	MT
05-08	Afya Limited, Q1 2026 Earnings Call, May 07, 2026

Evolution of the Average Target: Afya Limited

Evolution of the Target Price: Afya Limited

Changes in Analyst Recommendations: Afya Limited

c6d997d30f09f.jKv9lyRZZJ2_tUhtIwRCZ8qMOM2AV5LlW__YTqoHY2w.uvjEo1wDM9vUzAJAZHEhVOfjTYvrG9WxH7C-KuBMJja_hrXbexYD-pL_Kw~ed04c67e73bbfacc430236cc21480c92

Analysts' recommendations: Afya Limited

02-24	BofA Securities Downgrades Afya to Neutral From Buy, Price Target is $17	MT
02-13	Afya Shares Fall After Morgan Stanley Downgrade	MT
02-13	Morgan Stanley Downgrades Afya to Underweight From Equalweight, Adjusts Price Target to $16 From $17.50	MT
01-16	UBS Downgrades Afya to Neutral From Buy, Adjusts PT to $16 From $18	MT
01-08	UBS Trims Afya Price Target to $18 From $19, Maintains Buy Rating	MT
01-07	JPMorgan Downgrades Afya to Neutral From Overweight, Adjusts Price Target to $22 From $24.50	MT
08/09/25	UBS Upgrades Afya to Buy From Neutral, $19 Price Target	MT
08/09/25	JPMorgan Upgrades Afya to Overweight, Price Target is $24.50	MT
06/08/25	Afya Shares Rise After Morgan Stanley Upgrade	MT
06/08/25	Morgan Stanley Upgrades Afya to Equalweight From Underweight, Adjusts Price Target to $17.50 From $19	MT
29/07/25	Citigroup Upgrades Afya to Neutral From Sell, Adjusts Price Target to $14 From $16	MT
12/06/25	UBS Hikes Afya Price Target to $19.50 From $17.50, Maintains Neutral Rating	MT
11/03/25	Morgan Stanley Downgrades Afya to Underweight From Equal Weight, Cuts Price Target to $17 From $19	MT
05/02/25	Bradesco BBI Downgrades Afya to Underperform From Neutral, Adjusts Price Target to $14 From $17	MT
31/01/25	Citigroup Downgrades Afya to Sell From Neutral, Adjusts Price Target to $15 From $18	MT
17/12/24	UBS Cuts Price Target on Afya to $17.50 From $19.50, Keeps Neutral Rating	MT
30/08/24	UBS Initiates Coverage on Afya With Neutral Rating, Sets $19.50 Price Target	MT
21/06/24	Morgan Stanley Adjusts Price Target on Afya to $19 From $21, Maintains Equalweight Rating	MT
27/11/23	JPMorgan Downgrades Afya to Neutral From Overweight, Adjusts Price Target to $23 From $22	MT
22/11/22	Credit Suisse Adjusts Afya's Price Target to $18 From $19, Keeps Outperform Rating	MT
13/10/22	UBS Adjusts Afya Price Target to $18 From $21, Maintains Buy Rating	MT
08/04/22	Credit Suisse Upgrades Afya to Outperform from Neutral, Adjusts Price Target to $19 from $18	MT
07/03/22	UBS Adjusts Afya Price Target to $21 From $27, Maintains Buy Rating	MT
15/02/22	Goldman Sachs Adjusts Afya's Price Target to $19 From $29, Reiterates Buy Rating	MT
21/07/21	AFYA : Morgan Stanley Downgrades Afya to Equalweight from Overweight, Adjusts Price Target to $28.50 from $32	MT

More recommendations

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
GRAHAM HOLDINGS COMPANY	-	-	-14.65%
PHOENIX EDUCATION PARTNERS, INC.			+34.78%
COGNA EDUCAÇÃO S.A.			+75.36%
CHINA EDUCATION GROUP HOLDINGS LIMITED			+108.43%
YDUQS PARTICIPAÇÕES S.A.			+87.73%
VITRU EDUCAÇÃO S.A.			+42.91%
CAIRO FOR INVESTMENT AND REAL ESTATE DEVELOPMENTS-CIRA EDUCATION	-	-	-
SER EDUCACIONAL S.A.			+45.29%
Average			+54.27%
Weighted average by Cap.			+19.00%